Suplatast/tacrolimus combination therapy for refractory facial erythema in adult patients with atopic dermatitis - A meta-analysis study

Allergology International

Volumn 56, Issue 3, 2007, Pages 269-275

  Miyachi, Yoshiki ^a   Katayama, Ichiro ^b   Furue, Masutaka ^c  

^a KYOTO UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

Atopic dermatitis; Erythema; Meta analysis; Suplatast; Tacrolimus

Indexed keywords

SUPLATAST TOSYLATE; TACROLIMUS;

ACNE; ARTICLE; ATOPIC DERMATITIS; BURNING SENSATION; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DROWSINESS; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG WITHDRAWAL; ECZEMA; FACE ERYTHEMA; HERPES SIMPLEX; HUMAN; META ANALYSIS; MONOTHERAPY; OINTMENT; PRIORITY JOURNAL; SCORING SYSTEM; SKIN IRRITATION; SKIN MANIFESTATION; SUPERINFECTION; SYSTEMATIC REVIEW; TOPICAL TREATMENT;

EID: 34548857048     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.O-06-478     Document Type: Article

References (17)

1. Kawano S, Nakagawa H. The correlation between the level of anti-Malassezia furfur IgE antibodies and severities of face and neck dermatitis of patients with atopic dermatitis. Allergy 1995;44:128-133.
2. Hattori T. [Refractory facial lesion in patients with adult atopic dermatitis.] Acta Dermatol. (Kyoto) 1994;89:109-113 (in Japanese).
3. Oonuma S, Takekawa K, Okajima M et al. [Lanolin ointment induced contact dermatitis: clinical examination of 23 volunteers.] Jpn. J. Clin. Dermatol. 1997;51:597-601 (in Japanese).
4. Yasuno H, Kishimoto S. Effects of tacrolimus ointment on facial eruption, itch, and scratching in patients with atopic dermatitis. J. Dermatol. 2004;31:194-199.
5. Kurosawa M, Miyachi Y. [Pathophysiology of a skin disease: allergic inflammation of skin.] Jpn. J. Clin. Dermatol. 1995;49:54-59 (in Japanese).
6. Schreiber SL, Crabtree GR. The mechanism of action of cyclosporin A and FK506. Immunol. Today 1992;13:136-142.
7. Nakagawa H. [FK506 (tacrolimus) ointment use guideline over atopic dermatitis.] Jpn. J. Clin. Dermatol. 2000;54: 93-97 (in Japanese).
8. Yamaya H, Basaki Y, Togawa M et al. Down-regulation of Th2 cell-mediated murine peritoneal eosinophilia by antiallergic agents. Life Sciences 1995;56:1647-1654.
9. Kondo Y, Yazawa H, Jinpo K. [The effect of IPD on serum IL-5 level in atopic dermatitis patients.] Nishinihon J. Dermatol. 1999;61:84-87 (in Japanese).
10. Suto H, Mitsuishi K, Hira K et al. The effect of suplatast tosilate on immunological parameters for the patients with atopic dermatitis. Allergy 2000;49:1163-1172.
11. Tamaoki J, Kondo K, Sakai N et al. Effect of suplatast tosilate, a Th2 cytokine inhibitor, on steroid-dependent asthma: a double-blind randomised study. Lancet 2000; 356:273-278.
12. Amano H, Kanbe N, Higuchi T et al. [The clinical effect of suplatast tosilate for refractory facial erythema in patients with adult atopic dermatitis.] Acta Dermatol. (Kyoto) 1998; 93:323-329 (in Japanese).
13. The Cochrane Collaboration, In: RevMan (ed). 4.2 User Guide, 2005.
14. Petitti DB. Meta-Analysis, Decision Analysis and Cost-Effectiveness Analysis: Methods for Quantitative Synthesis in Medicine. London: Oxford University Press, 1994.
15. Matsumura Y, Miyachi Y. [The synergistic effect of suplatast tosilate and tacrolimus hydrate ointment on the "red face" of adult-type atopic dermatitis.] Skin Research 2002;1:42-46 (in Japanese).
16. Koga T, Terao H, Furue M et al. [The combined therapy of tacrolimus ointment and suplatast tosilate to refractory facial erythema in patients with adult atopic dermatitis.] Nishinihon J. Dermatol. 2003;65:375-380 (in Japanese).
17. Takenaka M, Sato S, Katayama I. [Combination therapy of suplatast tosilate and tacrolimus ointment over refractory facial erythema with adult atopic dermatitis.] Nishinihon J. Dermatol. 2005;67:247-251 (in Japanese).